Swiss hepatitis C sufferers to get full access to expensive drug

Swiss hepatitis C sufferers to get full access to expensive drug
By Anand Chandrasekhar
The Federal Office of Public Health has announced that it will make the hepatitis C drug Zepatier available to all patients from July 1. The 12-week treatment costs CHF31,000 ($31,952) per patient and was previously only available to those with an advanced form of the disease.
Continue reading...